Akira Murakami

Dr. Akira Murakami

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2007 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
MHMaiko Higuchi
Maiko Higuchi
Asako YamayoshiAsako Yamayoshi
Asako Yamayoshi
TYTakasei Yamaguchi
Takasei Yamaguchi
RIReiko Iwase
Reiko Iwase
TYTetsuji Yamaoka
Tetsuji Yamaoka
AMAkira Murakami
Akira Murakami
It has been reported that point mutations in genes are responsible for various cancers and the selective regulation of the gene expression is an important issue to develop a new type of anticancer drugs. In this report, we present a new type of antisense molecule that photo-cross-links to an oligoribonucleotide having a point mutation site in a sequence specific manner. 2'-O-psoralen-conjugated adenosine was synthesized in four steps from adenosine and introduced in the middle of an oligodeoxyribonucleotide (2'-Ps-oligo). Compared with 5'-O-psoralen-conjugated oligodeoxyribonucleotide (5'-Ps-oligo), which has a psoralen at the 5'-end, 2'-Ps-oligo more selectively photo-cross-linked to a pyrimidine base of the site of alteration from purine to pyrimidine in the oligoribonucleotide.

12 June 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Asako YamayoshiAsako Yamayoshi
Asako Yamayoshi
SOShota Oyama
Shota Oyama
YKYusuke Kishimoto
Yusuke Kishimoto
RKRyo Konishi
Ryo Konishi
TYTsuyoshi Yamamoto
Tsuyoshi Yamamoto
AMAkira Murakami
Akira Murakami
MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody–anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs.

26 November 2007 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
TSTakashi Sakamoto
Takashi Sakamoto
AKAkio Kobori
Akio Kobori
MSMasako Shigezawa
Masako Shigezawa
YAYasutaka Amitani
Yasutaka Amitani
MHMaiko Higuchi
Maiko Higuchi
AMAkira Murakami
Akira Murakami
We developed a bispyrene-conjugated 2 ′-O-methyloligoribonucleotide as an RNA-specific RNA-probe. The probe hybridized with the complementary RNA, greatly enhancing fluorescence and discriminating RNA from DNA. The assay was carried out in homogeneous aqueous media without removing the unbound probe from the detection solution. This homogeneous fluorescence assay also discriminated mismatch sequences in the target RNA. These pyrene probes could possess high potential to detect RNA in biological specimens simply.

25 May 1990 in ChemInform
Verified
Journal Article
Closed access
PDF file
HYH. Yamanaka
H. Yamanaka
AMAkira Murakami
Akira Murakami
MKM. Kuwabara
M. Kuwabara
KFK. Fukunishi
K. Fukunishi
MNM. Nomura
M. Nomura